Literature DB >> 7505974

PSA velocity for the diagnosis of early prostate cancer. A new concept.

H B Carter1, J D Pearson.   

Abstract

An evaluation of longitudinal changes in PSA in men with and without prostate disease revealed that with age, the development of prostate disease is the most important factor influencing changes in PSA. Furthermore, the PSA changes with age are significantly different in men with and without prostate disease. The PSA velocity is greater in men with prostate cancer than in men with BPH and greater in men with prostate cancer and BPH than in men without any prostate disease. Thus, evaluation of PSA changes may help distinguish between men with prostate cancer and those without the disease. This idea will need to be confirmed prospectively. Finally, estimation of PSA doubling time from changes in PSA suggests that changes reflect prostatic growth. Therefore, PSA velocity could be of benefit in identifying men with prostate cancer that is destined to progress.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7505974

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  14 in total

Review 1.  ABC of urology. Bladder outflow obstruction.

Authors:  C Dawson; H Whitfield
Journal:  BMJ       Date:  1996-03-23

2.  Prospective evaluation of prostate specific antigen (PSA), PSA density, free-to-total PSA ratio and a new formula (prostate malignancy index) for detecting prostate cancer and preventing negative biopsies in patients with normal rectal examinations and intermediate PSA levels.

Authors:  C Dinçel; T Caşkurlu; A I Taşçi; M Cek; G Sevin; A Fazlioğlu
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

3.  Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases.

Authors:  Anders Carlsson; Christer Wingren; Malin Kristensson; Carsten Rose; Mårten Fernö; Håkan Olsson; Helena Jernström; Sara Ek; Elin Gustavsson; Christian Ingvar; Mattias Ohlsson; Carsten Peterson; Carl A K Borrebaeck
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

Review 4.  Long non-coding RNA in prostate cancer.

Authors:  Christine An; Ian Wang; Xin Li; Rong Xia; Fangming Deng
Journal:  Am J Clin Exp Urol       Date:  2022-06-15

5.  Spectrophotometric photodynamic diagnosis of prostate cancer cells excreted in voided urine using 5-aminolevulinic acid.

Authors:  Yasushi Nakai; Makito Miyake; Satoshi Anai; Shunta Hori; Yoshihiro Tatsumi; Yosuke Morizawa; Sayuri Onisi; Nobumichi Tanaka; Kiyohide Fujimoto
Journal:  Lasers Med Sci       Date:  2018-05-04       Impact factor: 3.161

6.  Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.

Authors:  H Ballentine Carter; Luigi Ferrucci; Anna Kettermann; Patricia Landis; E James Wright; Jonathan I Epstein; Bruce J Trock; E Jeffrey Metter
Journal:  J Natl Cancer Inst       Date:  2006-11-01       Impact factor: 13.506

7.  Early Detection of Cancer: Immunoassays for Plasma Tumor Markers.

Authors:  Danni L Meany; Lori J Sokoll; Daniel W Chan
Journal:  Expert Opin Med Diagn       Date:  2009-11-01

8.  The use of multiphase nonlinear mixed models to define and quantify long-term changes in serum prostate-specific antigen: data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Authors:  Azza Shoaibi; Gowtham A Rao; Bo Cai; John Rawl; James R Hébert
Journal:  Ann Epidemiol       Date:  2015-10-28       Impact factor: 3.797

Review 9.  [Serum markers for early detection and staging of prostate cancer. Status report on current and future markers].

Authors:  A Haese; M Graefen; J Palisaar; E Huland; H Huland
Journal:  Urologe A       Date:  2003-09       Impact factor: 0.639

10.  Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone.

Authors:  David J Hernandez; Misop Han; Elizabeth B Humphreys; Leslie A Mangold; Samir S Taneja; Stacy J Childs; Georg Bartsch; Alan W Partin
Journal:  BJU Int       Date:  2008-10-24       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.